Bleeding prediction by rotational thromboelastometry in chronic hemodialysis patients with non-valvular atrial fibrillation on apixaban

Figure 2 Receiver operating characteristic curve analysis of rotational thromboelastometry with EXTEM reagent clotting time-post drug administration for the prediction of bleeding risk in hemodialysis patients on apixaban for non-valvular atrial fibrillation. AUC: Area under the curve.